Europe Blood Glucose Monitor Market

The Europe blood glucose monitor market is projected to reach USD 6.85 billion in 2030 from USD 4.75 billion in 2025, recording a CAGR of 7.6% during the forecast period.

The Europe blood glucose monitor market is driven by the strong emphasis placed by the public healthcare systems on managing chronic diseases, primarily diabetes. The growing trend toward outpatient and home-based care, as well as the physician preference for effective and guideline-supported monitoring systems, continue to fuel the demand for self-monitoring and continuous glucose monitoring systems. Furthermore, the efforts to enhance glycemic control and minimize diabetes-related complications contribute to the adoption of monitoring systems, especially in Western Europe. However, the market growth is tempered by the pricing pressures exerted by government-led procurement initiatives, tender-based purchasing, and stringent health technology assessment criteria. This may delay the adoption of advanced glucose monitoring systems in several European countries.

Prominent players in the Europe blood glucose monitor market include Abbott Laboratories (US), DexCom, Inc. (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd. (Switzerland), Sinocare (China), B. Braun SE (Germany), and Ascensia Diabetes Care Holdings AG (Switzerland). These key players adopt product developments and business expansions, among other strategies, to boost their presence and business reach.

To know about the assumptions considered for the study download the pdf brochure

For instance, in November 2024, Abbott Laboratories announced the opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland. This site is a global manufacturing center of excellence for Abbott’s diabetes care business.

Abbott Laboratories (US)

Abbott Laboratories is a healthcare leader operating in over 160 countries. Through its Medical Devices division, the company has built a strong presence in diabetes care, offering continuous and traditional blood glucose monitoring solutions under the FreeStyle brand. Its flagship FreeStyle Libre system, comprising sensors, test strips, data management software, and related accessories, has revolutionized glucose tracking by providing real-time insights for better diabetes management. Additionally, the launch of the Lingo continuous glucose monitoring system for broader health and wellness applications has further strengthened its position as an innovation leader in the blood glucose monitor market.

DexCom, Inc. (US)

DexCom, Inc. develops, manufactures, and commercializes real-time CGM systems that provide continuous, actionable insights into glucose levels without the need for routine fingersticks. The company’s flagship DexCom G6 and next-generation G7 systems, supported by integrated mobile applications and data platforms, enable improved glycemic control and patient engagement. With a strong presence across Europe and other regions, it has established itself as a key innovator and market leader in CGM solutions, driving advancements in digital health and diabetes care.

MARKET RANKING

The Europe blood glucose monitor market is shaped by a small group of well-established global players supported by strong reimbursement frameworks and growing adoption of advanced monitoring technologies. Abbott Laboratories leads the region, driven by the wide use of its FreeStyle Libre CGM systems across major European countries, supported by ease of use and strong clinician and patient acceptance. Dexcom is another prominent player in the CGM space, with increasing uptake of its G6 and G7 CGM platforms, particularly in specialist and digitally enabled care settings. Medtronic maintains a solid presence through its MiniMed insulin pump systems and Guardian CGM sensors, focusing on integrated and closed-loop diabetes management solutions. Roche continues to hold a stable position in Europe with its Accu-Chek portfolio, benefiting from long-standing physician familiarity and broad distribution. Ascensia Diabetes Care is also a key participant, with its Contour blood glucose monitoring systems widely used across Europe, particularly in routine and home-based diabetes management.

Related Reports:

Europe Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com